Patrick Turko

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes.

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes.

Journal: Journal of cutaneous pathology

Published: December 15, 2025

NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation.

NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation.

Journal: The EMBO journal

Published: July 17, 2025

Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.

Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.

Journal: Cancers

Published: May 01, 2025

Protocol for analysis of miRNAs in human melanoma cells.

Protocol for analysis of miRNAs in human melanoma cells.

Journal: STAR protocols

Published: December 29, 2024

p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p.

p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p.

Journal: Cell death & disease

Published: December 11, 2024

Incidence, severity and potential pathomechanism of immune-related pruritus in melanoma patients undergoing immune checkpoint inhibitor therapy.

Incidence, severity and potential pathomechanism of immune-related pruritus in melanoma patients undergoing immune checkpoint inhibitor therapy.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: October 21, 2024

Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes.

Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes.

Journal: International journal of molecular sciences

Published: August 01, 2024

The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individuals.

The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individuals.

Journal: Cell reports. Medicine

Published: July 08, 2024

Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients.

Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients.

Journal: The Journal of clinical investigation

Published: March 26, 2024

Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.

Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.

Journal: Cancers

Published: January 31, 2024

DNA Methyltransferase Inhibition Upregulates the Costimulatory Molecule ICAM-1 and the Immunogenic Phenotype of Melanoma Cells.

DNA Methyltransferase Inhibition Upregulates the Costimulatory Molecule ICAM-1 and the Immunogenic Phenotype of Melanoma Cells.

Journal: JID innovations : skin science from molecules to population health

Published: January 26, 2024

Patterns of radiological response to tebentafusp in patients with metastatic uveal melanoma.

Patterns of radiological response to tebentafusp in patients with metastatic uveal melanoma.

Journal: Melanoma research

Published: December 21, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026